Navigation Links
iCAD to Feature New Products and Capabilities at European Congress of Radiology

NASHUA, N.H., March 7 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced the company will demonstrate its latest CAD innovations at the second-largest radiological meeting in the world, the European Congress of Radiology (ECR), in Vienna, Austria, March 7 to 11 (booth #108).

At ECR, iCAD plans to showcase its SecondLook(R) suite of products, including an enhanced version of SecondLook Digital for Siemens. The technology now provides more detailed information about marked regions of interest and displays CAD marks based upon the certainty of the finding.

Additionally, customized SecondLook Digital CAD solutions for Agfa CR, Sectra and Planmed digital mammography systems will be displayed in iCAD's booth. SecondLook Digital will broaden and strengthen these solutions by providing enhanced detection and workflow capabilities, and will deliver powerful performance improvements increasing the radiologist's confidence.

iCAD also continues to develop CAD applications for CT Colonography and Tomosynthesis, and works-in-progress will be demonstrated in the booth. While still in development, these CAD solutions have the potential to provide superior identification capabilities and assist in improving accuracy and workflow during the reading process.

"Through pursuit of diverse partnerships and research of new applications, iCAD is expanding the opportunities for CAD, and we are excited to demonstrate this progress to the European audience at ECR," said Ken Ferry, President and Chief Executive Officer of iCAD. "As the market for CAD continues to grow, iCAD is committed to the continuous development and enhancement of products to improve the accuracy and consistency of cancer detection."

About iCAD, Inc.

iCAD, Inc. (Nasdaq: ICAD) is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over 1800 women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit

For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at

For iCAD Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn & Associates at 212-838-3777 x6604 or via email at

For iCAD Public Relations, contact Wendy Ryan of Schwartz Communications at 781-684-0770 or via email at

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:

Certain statements contained in this News Release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. lifesDHA(TM) Featured in New Ricos(R) Cheese Sauce
2. Boydens Summit Practice Featured in the September Issue of New Jersey Business Magazine
3. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
4. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
5. Synvista Therapeutics to be Featured on
6. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
7. Sol-gel inks produce complex shapes with nanoscale features
8. Astex Drug Candidates to be Featured at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. 49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases
10. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
Post Your Comments:
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... be speaking at the following conference, and invited investors ... York, NY      Tuesday, December 1, 2015 at ... York, NY      Tuesday, December 1, 2015 at ... Healthcare Conference, New York, NY ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - Aeterna ... request of IIROC on behalf of the Toronto Stock ... news release there are no corporate developments that would ... --> --> About ... . --> Aeterna Zentaris is ...
Breaking Biology Technology:
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
(Date:10/29/2015)... , Oct. 29, 2015 Today, ... a partnership with 2XU, a global leader in ... a smart hat with advanced bio-sensing technology. The ... athletes to monitor key biometrics to improve overall ... partnership, the two companies will bring together the most ...
(Date:10/27/2015)... Oct. 27, 2015 Synaptics Inc. (NASDAQ: SYNA ... that Google has adopted the Synaptics ® ClearPad ... to power its newest flagship smartphones, the Nexus 5X ... --> --> Synaptics ... provide strategic collaboration in the joint development of next ...
Breaking Biology News(10 mins):